The Sarbanes–Oxley Act and non-US issuers: Considerations for international companies

ISSN： 1478-565X

Source： Journal of Commercial Biotechnology, Vol.10, Iss.1, 2003-09, pp. : 40-53

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Growth of Indian biotech companies, in the context of the international biotechnology industry

By Palnitkar Utkarsh

Journal of Commercial Biotechnology, Vol. 11, Iss. 2, 2005-01 ,pp. : 146-154

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

US and international policies affecting liquid biofuels' expansion and profitability

By III Otto C. Doering

International Journal of Biotechnology, Vol. 11, Iss. 1-2, 2009-09 ,pp. : 150-167

Inderscience Publishers

Access to resources Recommend Favorite

'Coaching' small biotech companies into success

By Luukkonen Terttu Maunula Mari

International Journal of Biotechnology, Vol. 9, Iss. 6, 2007-11 ,pp. : 548-568

Inderscience Publishers

Access to resources Recommend Favorite

Australian biotech companies: Navigating the maze

By Herpin Timothy F Karuso Helen Foley James E

Journal of Commercial Biotechnology, Vol. 11, Iss. 2, 2005-01 ,pp. : 111-120

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

Bioethical concerns in Japanese biotechnology companies

By Kato Makina

Journal of Commercial Biotechnology, Vol. 12, Iss. 3, 2006-04 ,pp. : 205-212

Palgrave Macmillan Ltd

Access to resources Recommend Favorite